Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Company news > 2016

Company news, 2016

ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration

ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration

SAN DIEGO, Oct.

New molecule may help fight obesity

New molecule may help fight obesity

Researchers, including one of Indian-origin, have identified a new molecule that may help fight obesity and other metabolic diseases by converting 'bad' fat to 'good' fat.

Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis

Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis

NEW HAVEN, CT, USA I October 13, 2016 I Trevi Therapeutics, Inc.

ChemDiv is presenting at the SCI's event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK

ChemDiv is presenting at the SCI's event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK

ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence

ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence

A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union

A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union

SAN DIEGO, CA, June 22, 2016 - National Immunobiological Company (Rostec State Corporation) and ChemRar Pharma (ChemRar HTC) announced the signing of an agreement for joint development...

SatRx LLC Announces First Registration in Russia of SatRx® (gosogliptin), an Innovative Drug for Treatment of Type 2 Diabetes

SatRx LLC Announces First Registration in Russia of SatRx® (gosogliptin), an Innovative Drug for Treatment of Type 2 Diabetes

SAN DIEGO, CA, June 9, 2016 – Today, at the largest global biotech forum, BIO International Convention, that took place in San Francisco, USA, SatRx LLC, a ChemRar / ChemDiv, Inc co...

Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS

Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS

SAN DIEGO, May 11, 2016 /PRNewswire/ -- Viriom Inc.

ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets

ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets

January 14th, 2016 – The Chemical Diversity Research Institute of ChemDiv, Inc (ChemDiv), San Diego, CA – based global research organization and Abbott’s branded generics pharmaceutical ...

ChemDiv Announces Achievement of a Development Milestone in a Drug Discovery Collaboration With Janssen

ChemDiv Announces Achievement of a Development Milestone in a Drug Discovery Collaboration With Janssen

SAN FRANCISCO, CA--(Marketwired - Jan 11, 2016) - J.

1

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote